IceCure's Advanced Multiprobe Cryoablation Technology Receives Patent Approval in Japan
November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
MORE NEWS
January 31, 2026 - 23:21
Kristi Noem to hold news conference on technology development and investment in TSASouth Dakota Governor Kristi Noem is scheduled to convene a press conference this Saturday focused on the critical intersection of technological advancement and national security. The central topic...
January 31, 2026 - 00:05
International Glaucoma Symposium aims to bridge clinical practice and emerging technologyThe upcoming International Glaucoma Symposium in Mainz is set to directly address the integration of cutting-edge technology into daily eye care. The event`s program is strategically designed to...
January 30, 2026 - 05:17
Go Technology Report January 2026: Consumers and HospitalityNew research highlights the enduring importance of pubs, bars, restaurants, and hotels within their local communities, identifying the core factors that will drive consumer visits in the coming...
January 29, 2026 - 09:30
SEC Says Tokenized Assets Are Securities First, Technology SecondThe U.S. Securities and Exchange Commission (SEC) clarified its stance this week, emphasizing that the technological innovation behind a financial product does not override established legal...